$ENSC 8-K SEC Filings

Filed On	Filing
29 Sep 2026	8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Ensysce Biosciences, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (“DGCL”), DOES HEREBY CERTIFY:
25 Aug 2026	8-K: Other Events
24 Aug 2026	8-K: Other Events
13 Aug 2026	8-K: Results of Operations and Financial Condition
06 Aug 2026	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +5 more
15 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
22 May 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
15 May 2026	8-K: Results of Operations and Financial Condition
08 Apr 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
03 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
30 Mar 2026	8-K: Results of Operations and Financial Condition
30 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation
23 Mar 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
27 Feb 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
08 Jan 2026	8-K: Submission of Matters to a Vote of Security Holders
17 Nov 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
14 Nov 2025	8-K: Results of Operations and Financial Condition
13 Aug 2025	8-K: Results of Operations and Financial Condition
05 Jun 2025	8-K: Changes in Registrant's Certifying Accountant
13 May 2025	8-K: Results of Operations and Financial Condition

Comments